Home » All » Stock Forecast » Contineum Therapeutics Inc. Class A Common Stock Forecast

Contineum Therapeutics Inc. Class A Common Stock Forecasts for Tomorrow, Week, Month and 5 Years

Updated: April 22 · 2026 at 07:03 UTC

From

▼ -2.38%Market Cap $490.97M · Technical analysis Bearish · Focus area Price + volatility

Forecast Summary

Timeframe	Predicted Price	Past	Historical	Insight
Tomorrow	$13.01 ▼ -1.06%	Yesterday	$13.21 ▲ +0.45%	Tomorrow's Contineum Therapeutics Inc. Class A Common Stock (CTNM) setup is anchored to $13.15 and targets $13.01 (-1.06%). The near-term read is downside; watch $13.54 / $12.76 because daily realized volatility is about 5.47%.
Tomorrow's Contineum Therapeutics Inc. Class A Common Stock (CTNM) setup is anchored to $13.15 and targets $13.01 (-1.06%). The near-term read is downside; watch $13.54 / $12.76 because daily realized volatility is about 5.47%.
Week	$12.72 ▼ -3.30%	Last Week	$13.33 ▲ +1.39%	The 7-day Contineum Therapeutics Inc. Class A Common Stock model moves from $13.33 to $12.72 (-3.30%). It gives downside momentum context for this stock, so breaks around $13.54 / $12.76 matter more than a single tick.
The 7-day Contineum Therapeutics Inc. Class A Common Stock model moves from $13.33 to $12.72 (-3.30%). It gives downside momentum context for this stock, so breaks around $13.54 / $12.76 matter more than a single tick.
Month	$12.23 ▼ -7.03%	Last Month	$13.54 ▲ +2.95%	The 1-month Contineum Therapeutics Inc. Class A Common Stock target is $12.23 (-7.03%), compared with the live reference near $13.15. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Contineum Therapeutics Inc. Class A Common Stock target is $12.23 (-7.03%), compared with the live reference near $13.15. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Year	$11.49 ▼ -12.62%	Last Year	$13.85 ▲ +5.30%	The 1-year Contineum Therapeutics Inc. Class A Common Stock scenario points to $11.49 (-12.62%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Contineum Therapeutics Inc. Class A Common Stock scenario points to $11.49 (-12.62%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Years	$9.77 ▼ -25.71%	5 Years Ago	$14.57 ▲ +10.80%	The 5-year Contineum Therapeutics Inc. Class A Common Stock view is $9.77 (-25.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Contineum Therapeutics Inc. Class A Common Stock view is $9.77 (-25.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Tomorrow$13.01▼ -1.06%

Yesterday$13.21▲ +0.45%

Tomorrow's Contineum Therapeutics Inc. Class A Common Stock (CTNM) setup is anchored to $13.15 and targets $13.01 (-1.06%). The near-term read is downside; watch $13.54 / $12.76 because daily realized volatility is about 5.47%.

Week$12.72▼ -3.30%

Last Week$13.33▲ +1.39%

The 7-day Contineum Therapeutics Inc. Class A Common Stock model moves from $13.33 to $12.72 (-3.30%). It gives downside momentum context for this stock, so breaks around $13.54 / $12.76 matter more than a single tick.

Month$12.23▼ -7.03%

Last Month$13.54▲ +2.95%

The 1-month Contineum Therapeutics Inc. Class A Common Stock target is $12.23 (-7.03%), compared with the live reference near $13.15. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

Year$11.49▼ -12.62%

Last Year$13.85▲ +5.30%

The 1-year Contineum Therapeutics Inc. Class A Common Stock scenario points to $11.49 (-12.62%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

5 Years$9.77▼ -25.71%

5 Years Ago$14.57▲ +10.80%

The 5-year Contineum Therapeutics Inc. Class A Common Stock view is $9.77 (-25.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Price Chart

HistoricalForecastBullishBearish

Technical Analysis

Bearish

Bullish

Neutral

Bearish

Key Indicators

Indicator	Value	Signal
Price	$13.15	Mid
Daily Change	-2.38%	Below
Volatility Cap	20.0%	Mid
Confidence	62%	Below
Data Source	nasdaq-screener	Mid

Historical Data

Current$13.15

Daily Change-2.38%

Market Cap$490.97M

Sourcenasdaq-screener

Current	$13.15	Daily Change	-2.38%
Market Cap	$490.97M	Source	nasdaq-screener

Support & Resistance Levels

$12.76Support 1

$13.15Current

$13.54Resistance 1

Support and resistance are estimated from the trusted current price until deeper historical data is available.

Price Milestones

Key levels & historical context

Current$13.15Live reference price

Used as the anchor for generated forecast calculations.

Next Month$12.23Model projection-7.03%

Directional scenario based on capped drift.

Forecast Accuracy

How our model has performed

62%

Directional

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

Our algorithm is re-calibrated weekly using the latest price action, volatility regime, and indicator signals. Accuracy varies by timeframe — short-term momentum is more reliable than long-term projections.

Short term

62%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

Investment Scenarios

If you invest $1,000 in CTNM today

Bullish Scenario

$13.81

+5.00% from current

Target Price$13.81

ScenarioUpside momentum

Probability54%

Base Scenario

$12.23

-7.03%

Target Price$12.23

ScenarioCapped drift

Probability62%

Bearish Scenario

$12.49

-5.00% from current

Target Price$12.49

ScenarioVolatility drawdown

Probability38%

Basis: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Forecast Factors

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bearish · 35/100

24H drift-1.06%

7D drift-3.30%

30D drift-7.03%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-Off Caution · 27/100

1M outlook-7.03%

1Y outlook-12.62%

5Y outlook-25.71%

Frequently Asked Questions

Q What is the Contineum Therapeutics Inc. Class A Common Stock (CTNM) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Contineum Therapeutics Inc. Class A Common Stock is projected near $13.01 versus the current reference around $13.15. That implies a modeled move of -1.06% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for CTNM?

The weekly Contineum Therapeutics Inc. Class A Common Stock model points to $12.72, which maps to an expected drift of -3.30% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the Contineum Therapeutics Inc. Class A Common Stock 1-month and 1-year targets?

The Contineum Therapeutics Inc. Class A Common Stock 1-month target is $12.23 (-7.03%), while the 1-year target is $11.49 (-12.62%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the Contineum Therapeutics Inc. Class A Common Stock 5-year scenario differ from short-term rows?

The Contineum Therapeutics Inc. Class A Common Stock long-horizon scenario sits near $9.77 with a modeled change of -25.71%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are CTNM support and resistance zones right now?

For Contineum Therapeutics Inc. Class A Common Stock, nearest resistance is around $12.76, while nearest support is around $13.54. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the Contineum Therapeutics Inc. Class A Common Stock market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.